Niko-Lek Lemon (Nicotine)

Nicotine, the active ingredient in Niko-Lek Lemon, is a nicotinic receptor agonist presented as an oromucosal preparation for oromucosal use. It helps adults manage nicotine withdrawal symptoms during smoking cessation attempts. GNH USA supplies Niko-Lek Lemon as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Niko-Lek Lemon is a nicotinic receptor agonist used in the management of tobacco‑related dependence. - Smoking cessation: assists adults who want to quit smoking by reducing cravings. - Nicotine dependence: alleviates withdrawal symptoms during quit attempts. - Tobacco use disorder: supports reduction of cigarette consumption as part of a cessation program.

Niko-Lek Lemon may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Mouth irritation: discomfort or soreness in the oral cavity. - Nausea: feeling of queasiness or upset stomach. - Hiccups: involuntary diaphragm contractions. - Dizziness: light‑headed sensation. - Headache: mild to moderate pain in the head. - Throat irritation: scratchy feeling in the throat.

Serious or Rare Side Effects: - Cardiovascular events: chest pain, palpitations, or hypertension. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Arrhythmia: irregular heart rhythm. - Hypotension: unusually low blood pressure. - Seizures: rare neurological episodes.

When considering Niko-Lek Lemon, several safety measures should be observed. - Assess cardiovascular status: evaluate for recent heart events before use. - Avoid use in recent myocardial infarction: contraindicated in patients with recent heart attacks. - Do not combine with other nicotine products: risk of nicotine overdose. - Monitor for signs of nicotine toxicity: watch for nausea, vomiting, or rapid heart rate. - Store at ambient temperature: keep in the original pack, protect from moisture and heat.

Niko-Lek Lemon can interact with other substances, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis. - Other nicotine‑containing products: risk of cumulative nicotine toxicity. - CYP2A6 inhibitors: can raise nicotine plasma levels.

Moderate Interactions (Monitor Closely): - Caffeine: may enhance stimulant effects and cause jitteriness. - Alcohol: can amplify cardiovascular effects of nicotine. - Certain antihypertensives: may require blood pressure monitoring.